United States· US:59137-570_5b889707-a1a2-3fb8-e063-6294a90a3777

Hexatrione

A medicinal product containing triamcinolone hexacetonide, registered in United States by Medexus Pharma, Inc..

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedHexatrioneATC—REGISTER NO.US:59137-570_5b889707…PACKS LISTED1CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
TRIAMCINOLONE HEXACETONIDE
Manufacturer
Medexus Pharma, Inc.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 1

  • ndc11
    59137-570-01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Triamcinolone hexacetonide in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All triamcinolone hexacetonide products

Authorised across Europe · EMA

The same active substance is authorised in 14 EEA countries. Names it is sold under:

  • Austria · Trispan
  • Czechia · Trispan
  • Germany · Lederlon
  • Denmark · Lederspan, Trica
  • Spain · Bluxam
  • Finland · Lederspan, Trica
  • France · Hexatrione
  • United Kingdom (Northern Ireland) · Triamcinolone Hexacetonide Trispan
  • Iceland · Lederlon, Lederspan
  • Netherlands · Trispan
  • Norway · Lederspan, Trica
  • Portugal · Bluxam
  • Sweden · Lederspan, Trica
  • Slovenia · Trispan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1998f014-a2f8-4404-a1a1-b266d1077550
GET /v1/drugs/1998f014-a2f8-4404-a1a1-b266d1077550?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRA-ARTICULAR",
  "source": "ndc",
  "strength": "40",
  "substance": "TRIAMCINOLONE HEXACETONIDE",
  "productndc": "59137-570",
  "dosage_form": "INJECTION, SUSPENSION",
  "dea_schedule": null,
  "strength_unit": "mg/2mL",
  "application_number": null,
  "marketing_category": "UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE"
}

See everything about triamcinolone hexacetonide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.